» News » Dom's Take: The race for COVID-19 vaccine

Dom's Take: The race for COVID-19 vaccine

November 17, 2020 15:28 IST
Get Rediff News in your Inbox:

With COVID-19 infections across the world crossing the 50 million mark, the race is on for a vaccine amongst the pharmaceutical majors around the world.

Bringing a glimmer of hope, American biotech giant Moderna announced on Monday, November 16, that its COVID-19 vaccine has shown to be 94.5 per cent effective.

On November 9, the American company Pfizer Inc and and its German partner BioNTech said its vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19.

On the heels of the announcement by Pfizer about the efficacy of its vaccine, Russia claimed its Sputnik V vaccine had shown 92 per cent efficacy in preventing COVID-19, according to interim trial results announced by the country's health ministry.

Dominic Xavier wonders when human beings can access the vaccine and terminate the mayhem caused by the coronavirus.


Feature Presentation: Aslam Hunani/

Get Rediff News in your Inbox:
The War Against Coronavirus

The War Against Coronavirus